Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

ESMO open

Showing results (191-200 of 2,246) with videos related to

Pageof 225
Sort By:
ESMO Open|November 2, 2019
What is new on the horizon in melanoma brain metastasis?Kim Margolin
ESMO Open|July 9, 2021
Association of improved overall survival with decreased distant metastasis following asparaginase-based chemotherapy and radiotherapy for intermediate- and high-risk early-stage extranodal nasal-type NK/T-cell lymphoma: a CLCG studyX Zheng, X He, Y Yang, et al.
ESMO Open|July 9, 2021
Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphomaV Subbiah, S Kuravi, S Ganguly, et al.
ESMO Open|June 17, 2021
Cancer and hepatic steatosisR Paternostro, W Sieghart, M Trauner, et al.
ESMO Open|July 16, 2021
Clinical implications of isolated troponinemia following immune checkpoint inhibitor therapyD Delombaerde, D Vervloet, C Franssen, et al.
ESMO Open|July 25, 2021
Increased risk of diabetes in cancer survivors: a pooled analysis of 13 population-based cohort studiesY Xiao, H Wang, Y Tang, et al.
ESMO Open|May 10, 2025
Letter Re: Factors associated with first-to-second-line attrition among patients with metastatic breast cancer in the real worldE S Camoz, I D Onur, F Yildiz
ESMO Open|December 14, 2020
Examining policy cohesion for cervical cancer worldwide: analysis of WHO country reportsLaurie Elit, Rei Haruyama, Alessandra Gatti, et al.
ESMO Open|January 5, 2021
Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrenceT Magnes, S Wagner, A R Thorner, et al.
ESMO Open|January 5, 2021
ESMO20 YO for YO: highlights on new drugs in advanced breast cancer focusing on sacituzumab govitecan and alpelisibM Lambertini, K Punie
Pageof 225

Showing results (191-200 of 2,246) with videos related to

Sort By:
Pageof 225
ESMO Open|November 2, 2019
What is new on the horizon in melanoma brain metastasis?Kim Margolin
ESMO Open|July 9, 2021
Association of improved overall survival with decreased distant metastasis following asparaginase-based chemotherapy and radiotherapy for intermediate- and high-risk early-stage extranodal nasal-type NK/T-cell lymphoma: a CLCG studyX Zheng, X He, Y Yang, et al.
ESMO Open|July 9, 2021
Precision therapy with anaplastic lymphoma kinase inhibitor ceritinib in ALK-rearranged anaplastic large cell lymphomaV Subbiah, S Kuravi, S Ganguly, et al.
ESMO Open|June 17, 2021
Cancer and hepatic steatosisR Paternostro, W Sieghart, M Trauner, et al.
ESMO Open|July 16, 2021
Clinical implications of isolated troponinemia following immune checkpoint inhibitor therapyD Delombaerde, D Vervloet, C Franssen, et al.
ESMO Open|July 25, 2021
Increased risk of diabetes in cancer survivors: a pooled analysis of 13 population-based cohort studiesY Xiao, H Wang, Y Tang, et al.
ESMO Open|May 10, 2025
Letter Re: Factors associated with first-to-second-line attrition among patients with metastatic breast cancer in the real worldE S Camoz, I D Onur, F Yildiz
ESMO Open|December 14, 2020
Examining policy cohesion for cervical cancer worldwide: analysis of WHO country reportsLaurie Elit, Rei Haruyama, Alessandra Gatti, et al.
ESMO Open|January 5, 2021
Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrenceT Magnes, S Wagner, A R Thorner, et al.
ESMO Open|January 5, 2021
ESMO20 YO for YO: highlights on new drugs in advanced breast cancer focusing on sacituzumab govitecan and alpelisibM Lambertini, K Punie
Pageof 225